Skip to main content
. 2022 Nov 2;8(1):96–108. doi: 10.1016/j.ncrna.2022.10.004

Table 8.

ROC curve analysis for NEAT1, HOTAIR, and GAS5 in the CVS-HTN, CVS-NHTN patients, and the healthy control groups.

CVS-HTN patients vs. control
LncRNA AUC
95% CI
P-value Cut-off point Sensitivity (%) Specificity (%) Total accuracy
NEAT1 0.878 (0.786–0.969) <0.0001 1.39 94.6 100 97.3%
HOTAIR 0.796 (0.683–0.909) <0.0001 0.68 81.5 100 90.75
GAS5 0.939 (0.872–1.000) <0.0001 0.82 96.8 100 98.4
CVS-NHTN patients vs. control
LncRNA AUC
95% CI
P-value Cut-off point Sensitivity (%) Specificity (%) Total accuracy
NEAT1 0.857 (0.759–0.955) <0.0001 1.33 91.2 100 95.6
HOTAIR 0.776 (0.659–0.892) <0.0001 0.75 75.8 100 87.9
GAS5 0.898 (0.813–0.983) <0.0001 0.84 91.9 100 95.95
CVS-HTN patients vs. CVS-NHTN patients
LncRNA AUC
95% CI
p-value Cut-off point Sensitivity (%) Specificity (%) Total accuracy
NEAT1 0.585 (0.402–0.715) 0.455 3.83 86.4 55.95 71.17
HOTAIR 0.562
0.411–0.713)
0.426 0.47 65.3 59.14 62.22
GAS5 0.733 (0.603–0.863) 0.003 0.37 81.68 69.77 75.72